|
1
|
Driancourt MA and Thuel B: Control of
oocyte growth and maturation by follicular cells and molecules
present in follicular fluid. A review. Reprod Nutr Dev. 38:345–362.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Edwards RG: Follicular fluid. J Reprod
Fertil. 37:189–219. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong CY, Chao HT, Lee SL and Wei YH:
Modification of human sperm function by human follicular fluid: A
review. Int J Androl. 16:93–96. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mahadevan MM and Fleetham J: Relationship
of a human oocyte scoring system to oocyte maturity and fertilizing
capacity. Int J Fertil. 35:240–244. 1990.PubMed/NCBI
|
|
5
|
Wu R, Van der Hoek KH, Ryan NK, Norman RJ
and Robker RL: Macrophage contributions to ovarian function. Hum
Reprod Update. 10:119–133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brännström M and Norman RJ: Involvement of
leukocytes and cytokines in the ovulatory process and corpus luteum
function. Hum Reprod. 8:1762–1775. 1993.PubMed/NCBI
|
|
7
|
Smith MP, Flannery GR, Randle BJ, Jenkins
JM and Holmes CH: Leukocyte origin and profile in follicular
aspirates at oocyte retrieval. Hum Reprod. 20:3526–3531. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moos J, Filova V, Pavelkova J, Moosova M,
Peknicova J and Rezabek K: Follicular fluid and serum levels of
inhibin A and pregnancy-associated plasma protein A in patients
undergoing IVF. Fertil Steril. 91:1739–1744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Browne RW, Bloom MS, Shelly WB, Ocque AJ,
Huddleston HG and Fujimoto VY: Follicular fluid high density
lipoprotein-associated micronutrient levels are associated with
embryo fragmentation during IVF. J Assist Reprod Genet. 26:557–560.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lédée N, Frydman R, Osipova A, et al:
Levels of follicular G-CSF and interleukin-15 appear as noninvasive
biomarkers of subsequent successful birth in modified natural in
vitro fertilization/intracytoplasmic sperm injection cycles. Fertil
Steril. 95:94–98. 2009. View Article : Google Scholar
|
|
11
|
Hasegawa J, Iwasaki S, Yanaihara A,
Negishi M, Tahara R and Okai T: Correlations between steroids
concentration in follicular fluid, pronuclear morphology and embryo
qualities in vitro fertilization. Reprod Med Biol. 2:171–176. 2003.
View Article : Google Scholar
|
|
12
|
De Mola Loret JR, Flores JP, Baumgardner
GP, Goldfarb JM, Gindlesperger V and Friedlander MA: Elevated IL-6
levels in the ovarian hyperstimulation syndrome: Ovarian
immunohistochemical localization of IL-6 signal. Obstet Gynecol.
87:581–587. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stewart CL: LIF and the regulation of the
preimplantation development of the mammalian embryo. Mol Reprod
Dev. 39:233–238. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Branisteanu I, Pijnenborg R, Spiessens C,
Van der Auwera I, Keith JC Jr and Van Assche FA: Detection of
immunoreactive interleukin-11 in human follicular fluid:
Correlations with ovarian steroid, insulin-like growth factor I
levels, and follicular maturity. Fertil Steril. 67:1054–1058. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Belayet HM, Kanayama N, Khatun S, Asahina
T, Okada Y, Kitamura K, Kobayashi T and Terao T: Pharmacologic
doses of interleukin 8 suppositories induce follicular maturation
in rabbits. Cytokine. 12:361–367. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arici A, Oral E, Bukulmez O, Buradagunta
S, Engin O and Olive DL: Interleukin-8 expression and modulation in
human preovulatory follicles and ovarian cells. Endocrinology.
137:3762–3769. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lotze MT and Tracey KJ: High-mobility
group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal.
Nat Rev Immunol. 5:331–342. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Bloom O, Zhang M, et al: HMG-1 as
a late mediator of endotoxin lethality in mice. Science.
285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scaffidi P, Misteli T and Bianchi ME:
Release of chromatin protein HMGB1 by necrotic cells triggers
inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamada S and Maruyama I: HMGB1, a novel
inflammatory cytokine. Clin Chim Acta. 375:36–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Andersson U, Wang H, Palmblad K, et al:
High mobility group 1 protein (HMG-1) stimulates proinflammatory
cytokine synthesis in human monocytes. J Exp Med. 192:565–570.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erlandsson Harris H and Andersson U:
Mini-review: The nuclear protein HMGB1 as a proinflammatory
mediator. Eur J Immunol. 34:1503–1512. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andersson U and Harris HE: The role of
HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys
Acta. 1799:141–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Steer CV, Mills CL, Tan SL, Campbell S and
Edwards RG: The cumulative embryo score: A predictive embryo
scoring technique to select the optimal number of embryos to
transfer in vitro fertilization and embryo transfer programme. Hum
Reprod. 7:117–119. 1992.PubMed/NCBI
|
|
25
|
Cantineau AE, Cohlen BJ and Dutch IUI:
Study Group: The prevalence and influence of luteinizing hormone
surges in stimulated cycles combined with intrauterine insemination
during a prospective cohort study. Fertil Steril. 88:107–112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huirne JA, van Loenen AC, Schats R,
McDonnell J, Hompes PG, Schoemaker J, Homburg R and Lambalk CB:
Dose-finding study of daily GnRH antagonist for the prevention of
premature LH surges in IVF/ICSI patients: Optimal changes in LH and
progesterone for clinical pregnancy. Hum Reprod. 20:359–367. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tabibzadeh S: Molecular control of the
implantation window. Hum Reprod Update. 4:465–471. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abdulahad DA, Westra J, Limburg PC,
Kallenberg CG and Bijl M: HMGB1 in systemic lupus Erythematosus:
Its role in cutaneous lesions development. Autoimmun Rev.
9:661–665. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Check JH, Cohen R, Amui J, Choe JK and
Brasile D: Evidence that the main adverse effect of ganirelix on
pregnancy and implantation rates is on the embryo rather than the
endometrium. Clin Exp Obstet Gynecol. 38:326–327. 2011.PubMed/NCBI
|
|
30
|
Kehila M, Kebaili S, Bougmiza I, Meddeb S,
Boughizane S, Khairi H and Ajina M: Endometrial thickness in in
vitro fertilization. A study of 414 cases. Tunis Med. 88:928–932.
2010.[(In French)]. PubMed/NCBI
|
|
31
|
Chen SL, Wu FR, Luo C, Chen X, Shi XY,
Zheng HY and Ni YP: Combined analysis of endometrial thickness and
pattern in predicting outcome of in vitro fertilization and embryo
transfer: A retrospective cohort study. Reprod Biol Endocrinol.
8:30–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Okohue JE, Onuh SO, Ebeigbe P, Shaibu I,
Wada I, Ikimalo JI and Okpere EE: The effect of endometrial
thickness on in vitro fertilization (IVF)-embryo
transfer/intracytoplasmic sperm injection (ICSI) outcome. Afr J
Reprod Health. 13:113–121. 2009.PubMed/NCBI
|
|
33
|
Al-Ghamdi A, Coskun S, Al-Hassan S,
Al-Rejjal R and Awartani K: The correlation between endometrial
thickness and outcome of in vitro fertilization and embryo transfer
(IVF-ET) outcome. Reprod Biol Endocrinol. 6:37–41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rashidi BH, Sadeghi M, Jafarabadi M and
Tehrani Nejad ES: Relationships between pregnancy rates following
in vitro fertilization or intracytoplasmic sperm injection and
endometrial thickness and pattern. Eur J Obstet Gynecol Reprod
Biol. 120:179–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kovacs P, Matyas S, Boda K and Kaali SG:
The effect of endometrial thickness on IVF/ICSI outcome. Hum
Reprod. 18:2337–2341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuval Y, Lipitz S, Dor J and Achiron R:
The relationships between endometrial thickness, and blood flow and
pregnancy rates in in-vitro fertilization. Hum Reprod.
14:1067–1071. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Csemiczky G, Wramsby H, Johannisson E and
Landgren BM: Endometrial evaluation is not predictive for in vitro
fertilization treatment. J Assist Reprod Genet. 16:113–116. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oliveira JBA, Baruffi RLR, Mauri AL,
Petersen CG, Borges MC and Franco JG Jr: Endometrial
ultrasonography as a predictor of pregnancy in an in-vitro
fertilization programme after ovarian stimulation and
gonadotrophin-releasing hormone and gonadotrophins. Hum Reprod.
12:2515–2518. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Richter KS, Bugge KR, Bromer JG and Levy
MJ: Relationship between endometrial thickness and embryo
implantation, based on 1,294 cycles of in vitro fertilization with
transfer of two blastocyst-stage embryos. Fertil Steril. 87:53–59.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kovacs P, Matyas S, Boda K and Kaali SG:
The effect of endometrial thickness on IVF/ICSI outcome. Hum
Reprod. 18:2337–2341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Traub ML, Van Arsdale A, Pal L, Jindal S
and Santoro N: Endometrial thickness, Caucasian ethnicity, and age
predict clinical pregnancy following fresh blastocyst embryo
transfer: A retrospective cohort. Reprod Biol Endocrinol. 7:332009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He Q, Liang CH and Lippard SJ: Steroid
hormones induce HMG1 overexpression and sensitize breast cancer
cells to cisplatin and carboplatin. Proc Natl Acad Sci USA.
97:5768–5772. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Borrmann L, Kim I, Schultheiss D, Rogalla
P and Bullerdiek J: Regulation of the expression of HMG1, a
co-activator of the estrogen receptor. Anticancer Res. 21((1A)):
301–305. 2001.PubMed/NCBI
|
